GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Results] 45 weeks, 14kg, and tirzepatide was the hard part — 47 comments in the full submission. View in context.
3.2k
c/tirzepatide·submitted 4 months ago by u/copay_card_cc

[Results] 45 weeks, 14kg, and tirzepatide was the hard part

Resultsbranch of 8 comments

45 weeks, 14kg, and tirzepatide was the hard part, logged the same way every week so the comparison is at least internally fair. The numbers the title promised, since a headline without them is worthless: 45 weeks and 14kg. Everything below is context for those. It is a dual GIP and GLP-1 receptor agonist, and the…

Read the full submission and all 47 comments →

This branch

8 comments, started 3 months ago
u/rania_marchand216 points·3 months ago

Sulphur burps for the first eight days after each step, then nothing. Predictable enough that I planned my week around it.

replysharereportpermalink
u/priya_guerrero55 points·3 months ago

2.5mg is a four-week starting dose, not a maintenance dose. Worth being precise since people search these threads.

replysharereportpermalink
u/emil_wojcik19 points·3 months ago

the constipation profile is genuinely gentler than people expect coming from sema

replysharereportpermalink
u/dario_vermeulen28 points·3 months ago

Went 10 to 12.5 on the calendar and had the worst fortnight of the whole run. Dropped back to 10 and everything settled.

replysharereportpermalink
u/aurel_lindqvist17 points·3 months ago·edited

Went 10 to 12.5 on the calendar and had the worst fortnight of the whole run.

Agreed, with one qualifier: that is the mean of the top arm and the spread around it was enormous.

replysharereportpermalink
u/ahmed_iyer26 points·3 months ago

Disagree with the conversion table. There is no validated equivalence between the two molecules and posting one as though there is does real damage.

replysharereportpermalink
u/incretin_ivypharmacology14 points·3 months ago

Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.

replysharereportpermalink
u/sanne_novak17 points·3 months ago

switching from sema is not a dose conversion, there is no clean equivalence

replysharereportpermalink

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.